IC
IMVT icon

Ikarian Capital’s Immunovant IMVT Stock Holding History

Ikarian Capital’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-600
Closed -$12.6K – 193
2024
Q4 		$14.9K Buy
+600
New +$17K ﹤0.01% 164
2024
Q3 		– Sell
-276,925
Closed -$8.17M – 161
2024
Q2 		$7.31M Hold
276,925
– – 1.27% 25
2024
Q1 		$8.95M Buy
276,925
+43,531
+19% +$1.59M 0.98% 32
2023
Q4 		$9.83M Sell
233,394
-64,400
-22% -$2.37M 0.92% 35
2023
Q3 		$11.4M Buy
+297,794
New +$6.73M 1.38% 19
2023
Q2 		– Sell
-774,398
Closed -$14.4M – 149
2023
Q1 		$12M Sell
774,398
-192,302
-20% -$3.34M 2.73% 5
2022
Q4 		$17.2M Buy
966,700
+155,000
+19% +$1.95M 4.14% 3
2022
Q3 		$4.53M Buy
+811,700
New +$3.97M 0.9% 40
2021
Q4 		– Sell
-83,046
Closed -$722K – 213
2021
Q3 		$722K Sell
83,046
-102,454
-55% -$924K 0.05% 174
2021
Q2 		$1.96M Buy
+185,500
New +$2.59M 0.16% 131
2021
Q1 		– Sell
-235,587
Closed -$6.21M – 315
2020
Q4 		$10.9M Sell
235,587
-86,300
-27% -$3.99M 0.48% 49
2020
Q3 		$11.3M Buy
321,887
+39,724
+14% +$1.19M 0.82% 33
2020
Q2 		$6.87M Sell
282,163
-560,300
-67% -$12M 0.55% 58
2020
Q1 		$13.1M Buy
842,463
+338,346
+67% +$5.09M 0.99% 25
2019
Q4 		$8M Buy
+504,117
New +$5.65M 1.3% 22

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Ikarian Capital's IMVT Position: Q1 2025 in Review

Ikarian Capital sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 600 shares — an estimated $12.6K sold.

Ikarian Capital first reported a position in IMVT in Q4 2019 and held it in 15 quarters. The position peaked at $17.2M in Q4 2022. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Ikarian Capital reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Ikarian Capital sold 600 Immunovant shares in Q1 2025, an estimated $12.6K.
  • Ikarian Capital first reported a position in Immunovant in Q4 2019 and held it in 15 quarters.
  • Ikarian Capital's Immunovant position peaked at $17.2M in Q4 2022.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Ikarian Capital's 13F filing for Q1 2025, filed 15 May 2025.